PODD (Insulet Corp) Return on Sales by Gross Profit

PODD (Insulet Inc.) - company brandmark

Insulet Corporation demonstrates steady cash flow and high profitability through the implementation of wireless systems. Exclusive patents and stringent FDA oversight create a powerful barrier to entry for competitors. Patient dependence on smart pumps allows the company to maintain premium pricing power. The average gross margin confirms this strategy, and its value has stabilized at 72.90.

Insulet Corporation (PODD): Gross Margin from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Insulet Corporation (PODD)

- stock quotes and analyst forecast:
- business market valuation indicators:
Fundamental valuation:PODD Insulet Corp
Finished products of Insulet Inc.

For Insulet Corporation (PODD), the gross margin determines the production efficiency of smart pumps relative to sales volumes. This metric is calculated as the remaining revenue after deducting direct production costs, reflecting the internal profitability of each unit. By analyzing the gross margin ratio, an investor assesses the company's ability to contain costs while implementing expensive ESG standards for plastic recycling. The stability of this indicator confirms the resilience of the business model to ecological transformation.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin ZBH|Gross Margin coopercos.com (COO)|Gross Margin ALGN (aligntech.com)|Gross Margin Globus Medical Inc GMED|TMDX - Gross Profitability|ATEC: Gross Profitability|AORT (Artivion, Inc.) - Return on Gross Profit|Enovis Corporation - Gross Profit Rate|IART (Integra LifeSciences Inc.) - Gross Margin|Gross Profit Margin Establishment Labs Corp ESTA|Gross Profitability Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO